UK
GSK
#Biotherapies
UK
Xenothera is developing a new antibody-based treatment of animal origin to heal Covid-19 and other…
The company from Saint-Nazaire AlgoSource is developing an innovative solution based on microalgae. Its purpose…
UK | The international healthcare company, GSK, with around 100,000 employees, chose to set up…